Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets
- PMID: 33993109
- PMCID: PMC10613330
- DOI: 10.3899/jrheum.201594
Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets
Abstract
Objective: Systemic sclerosis (SSc) is a multisystem disease with heterogeneity in presentation and prognosis.An international collaboration to develop new SSc subset criteria is underway. Our objectives were to identify systems of SSc subset classification and synthesize novel concepts to inform development of new criteria.
Methods: Medline, Cochrane MEDLINE, the Cumulative Index to Nursing and Allied Health Literature, EMBASE, and Web of Science were searched from their inceptions to December 2019 for studies related to SSc subclassification, limited to humans and without language or sample size restrictions.
Results: Of 5686 citations, 102 studies reported original data on SSc subsets. Subset classification systems relied on extent of skin involvement and/or SSc-specific autoantibodies (n = 61), nailfold capillary patterns (n = 29), and molecular, genomic, and cellular patterns (n = 12). While some systems of subset classification confer prognostic value for clinical phenotype, severity, and mortality, only subsetting by gene expression signatures in tissue samples has been associated with response to therapy.
Conclusion: Subsetting on extent of skin involvement remains important. Novel disease attributes including SSc-specific autoantibodies, nailfold capillary patterns, and tissue gene expression signatures have been proposed as innovative means of SSc subsetting.
Keywords: autoimmune diseases; scleroderma; systemic sclerosis.
Copyright © 2021 by the Journal of Rheumatology.
Conflict of interest statement
The authors declare no conflicts of interest relevant to this article.
Figures
References
-
- Hinchcliff M, Varga J. Systemic sclerosis/scleroderma: a treatable multisystem disease. Am Fam Physician 2008;78:961–8. - PubMed
-
- Olsen NJ, King LE Jr, Park JH. Muscle abnormalities in scleroderma. Rheum Dis Clin North Am 1996;22:783–96. - PubMed
-
- Steen VD. The lung in systemic sclerosis. J Clin Rheumatol 2005;11:40–6. - PubMed
-
- Rose S, Young MA, Reynolds JC. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 1998;27:563–94. - PubMed
-
- Steen VD. Renal involvement in systemic sclerosis. Clin Dermatol 1994;12:253–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical